Genome Research Group Issues Corporate Update and Outlines Objectives

LONDON--(Marketwire - September 2, 2010) -  Genome Research Group (GRG) (PINKSHEETS: KKUR) recently announced its intended merger with ChromoCure, Inc. and consolidation of the operations and technologies of both groups. Genome Research Group personnel have assumed all executive and board duties and have no current or planned operations in the USA.

Comments

Leave a Reply